title: Is Subdural Peritoneal Shunt Placement an Effective Tool for the Management of Recurrent/Chronic Subdural Hematoma?
abstract: OBJECTIVE : To describe a surgical technique and to report using a retrospective study the efficacy of peritoneal shunts for the treatment of recurrent/chronic subdural hematoma (CSDH). We describe the considerations, complications, and outcomes related to this technique. METHODS : In a retrospective cohort study, 125 charts with a diagnosis of subacute/chronic subdural hematoma were assigned for evaluation. Of the charts reviewed, 18 charts were found from subjects with a diagnosis of recurrent sub-acute or chronic subdural hematoma. All patients had undergone initial surgical treatment of their condition followed by peritoneal shunt placement to help alleviate intracranial pressure. Factors including the age, size of subdural hematoma, number of previous events, BMI, complications, survival, and clinical course were analyzed. RESULTS : After subdural peritoneal shunt placement all patients had full neurological recovery with no complaints of headaches, lethargy, weakness, confusion or seizures. None of the cases had new subdural hematoma episodes after placement for a minimum of a two-year period (mean 26.1 months) (range 24.3-48.6 months). No postoperative complications were reported. The rates of postoperative hemorrhage, infection, distal catheter revision, and perioperative seizures was found to be zero percent. Shunt drainage was successful in all cases, draining 85% of the blood in the first 48 hours. There was no significant relationship between complications and the use of anticoagulants four weeks after surgery.
  
  
  CONCLUSIONS
  Peritoneal shunts, though rarely used, are a viable option in the treatment of sub-acute/chronic subdural hematomas. When pursuing this treatment, this technique is recommended to mitigate the risks of repeat surgical intervention and lessen perioperative time in high-risk patients.
authors.affiliation: Miami Neuroscience Center, Larkin Community Hospital ; Biotechnology - NeuroOncology, Biotechnology Advanced Academic Programs | Johns Hopkins University.
authors.forename: Andres M
authors.initials: AM
authors.lastname: Alvarez-Pinzon
authors.affiliation: Charles E. Schmidt College of Medicine, Florida Atlantic University ; Miami Neuroscience Center, Larkin Community Hospital.
authors.forename: Alan A
authors.initials: AA
authors.lastname: Stein
authors.affiliation: Miami Neuroscience Center, Larkin Community Hospital.
authors.forename: Jose E
authors.initials: JE
authors.lastname: Valerio
authors.affiliation: Miami Neuroscience Center, Larkin Community Hospital.
authors.forename: Victor
authors.initials: V
authors.lastname: Delgado
authors.affiliation: Miami Neuroscience Center, Larkin Community Hospital.
authors.forename: Jennifer A
authors.initials: JA
authors.lastname: Escalante
authors.affiliation: Neurosurgery, Florida International University.
authors.forename: Nithia
authors.initials: N
authors.lastname: Lopez
authors.affiliation: Miami Neuroscience Center, Larkin Community Hospital.
authors.forename: Aizik L
authors.initials: AL
authors.lastname: Wolf
keywords: craniotomy; mental status; shunt; subdural hematoma; trauma